Weight Loss Clinic - Saxenda
Transform into a healthier, fitter version of yourself with our weight loss clinic. We provide personalized services tailored to your specific needs and health requirements.
Saxenda
Saxenda (liraglutide) is a prescription-only, once daily weight loss injection, licensed to treat those with obesity (BMI of above 30) or who are overweight (BMI of above 27 with additional weight related comorbidities). It contains the medicine liraglutide. It should be used alongside a healthy and balanced diet and exercise to help aid weight loss.
Indication
To reduce weight in obese patients with an initial Body Mass Index (BMI) of ≥ 30 kg/m2 or overweight patients with BMI ≥27 kg/m2 to <30 kg/m2 and weight-related comorbidities.
Inclusion Criteria
Valid consent has been obtained from the patient/carer who does not want to consult with their GP and would prefer to have treatment from the PGD user.
- Patients aged between 18 and 74 years.
- Patients with an initial BMI of 30 kg/m2 or greater.
- Patients in which a supervised diet, behaviour modification and increasing physical activity failed to achieve a realistic reduction in weight.
- Patients with an initial BMI of 27 kg/m2 or greater in the presence of at least one weight-related comorbidity such as:
- Hypertension
- Dyslipidaemia
- Obstructive sleep apnoea
- Dysglycaemia (pre-diabetes or type 2 diabetes mellitus)
Healthcare professionals must be able to justify the decision to supply Saxenda to patients with a BMI ≥27 kg/m2 to <30kg/m². The patient must have a health condition that is either caused or exacerbated by their weight, and that is likely to be either resolved or improved by weight loss.